参考文献
1 Aparicio S，Sawant S，Lara N，et al．Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF．Biochem Biophys Res Commun，2005，326（2）：387—394
2 Apte RS，Barreiro RA，Duh E，et al．Stimulation of neovascularization by the anti－angiogenic factor PEDF．Invest Ophthalmol Vis Sci，2004，45（12）：4491—4497
3 Ren JG，Jie C，Talbot C．How PEDF prevents angiogenesis：a hypothesized pathway．Med Hypotheses，2005，64（1）：74—78
4 Sawant S，Aparicio S，Tink AR，et al．Regulation of factors controlling angiogenesis in liver development：a role for PEDF in the formation and maintenance of normal vasculature．Biochem Biophys Res Commun，2004，325（2）：408—413
5 Werdich XQ，McCollum GW，Rajaratnam VS，et al．Variable oxygen and retinal VEGF levels：correlation with incidence and severity of pathology in a rat model of oxygen－induced retinopathy．Exp Eye Res，2004，79（5）：623—630
6 Maik－Rachline G，Shaltiel S，Seger R．Extracellular phosphorylation converts pigment epithelium－derived factor from a neurotrophic to an antiangiogenic factor．Blood，2005，105（2）：670—678
7 Campochiaro PA．Ocular neovascularisation and excessive vascular permeability．Expert Opin Biol Ther，2004，4（9）：1395—1402
8 Garcia M，Fernandez－Garcia NI，Rivas V，et al．Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic／antitumor activities of pigment epithelium－derived factor．Cancer Res，2004，64（16）：5632—5642
9 Eichler W，Yafai Y，Keller T，et al．PEDF derived from glial Muller cells：apossible regulator of retinal angiogenesis．Exp Cell Res，2004，299（1）：68—78
10 Barnstable CJ，Tombran－Tink J．Neuroprotective and antiangiogenic actions of PEDF in the eye：molecular targets and therapeutic potential．Prog Retin Eye Res，2004，23（5）：561—577
11 Matsumoto K，Ishikawa H，Nishimura D，et al．Antiangiogenic property of pigment epithelium－derived factor in hepatocellular carcinoma．Hepatology，2004，40（1）：252—259
12 Stitt AW，Graham D，Gardiner TA．Ocular wounding prevents pre－retinal neovascularization and upregulates PEDF expression in the inner retina．Mol Vis，2004，10：432—438
13 Tombran－Tink J，Lara N，Chappa A，et al．Identification of downstream mechanisms involved in PEDF’S activity in the retina by large scale gene expression profiling．Adv Exp Med Biol，2003，533：315—326
14 Shao C，Sima J，Zhang SX，et al．Suppression of corneal neovascularization by PEDF release from human amniotic membranes．Invest Ophthalmol Vis Sci，2004，45（6）：1758—1762
15 Matsuoka M，Ogata N，Otsuji T，et al．Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy．Br J Ophthalmol，2004，88（6）：809—815
16 Duh EJ，Yang HS，Haller JA，et al．Vitreous levels of pigment epithelium－derived factor and vascular endothelial growth factor：implications for ocular angiogenesis．Am J Ophthalmol，2004，137（4）：668—674
17 Tombran－Tink J，Barnstable CJ．Osteoblasts and osteoclasts express PEDF，VEGF－A isoforms，and VEGF receptors：possible mediators of angiogenesis and matrix remodeling in the bone．Biochem Biophys Res Commun，2004，316（2）：573—579
18 Campochiaro PA，Hackett SF．Ocular neovascularization：a valuable model system．Oncogene，2003，22（42）：6537—6548
19 Schmidt－Erfurth U，Schlotzer－Schrehard U，Cursiefen C，et al．Influence of photodynamic therapy on expression of vascular endothelial growth factor（VEGF），VEGF receptor 3and pigment epithelium－derived factor．Invest Ophthalmol Vis Sci，2003，44（10）：4473—4480
20 Kim SY，Mocanu C，Mcleod DS，et al．Expression of pigment epitheliumderived factor（PEDF）and vascular endothelial growth factor（VEGF）in sickle cell retina and choroid．Exp Eye Res，2003，77（4）：433—445
21 Boehm BO，Lang G，Feldmann B，et al．Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti－angiogenic agent pigment epithelium－derived factor（PEDF）in aqueous humor．a pilot study．Horm Metab Res，2003，35（6）：382—386
22 Hohenester E，Sasaki T，Mann K，et al．Variable zinc coordination in endostatin．J Mol Biol，2000，297：1—6
23 Sasaki T，Larsson H，Tisi D，et al．Endostatin derived from collagens XV andⅩⅧdiffer in structural and binding properties，tissue distribution and anti－angiogenic activity．J Mol Biol，2000，301：1179—1190
24 Noma H，Funatsu H，Yamashita H，et al．Regulation of angiogenesis in diabetic retinopathy：possible balance between vascular endothelial growth factor and endostatin．Arch Ophthalmol，2002，120：1075—1080 25 Dong S，Landfair J，Balasubramani M，et al．Expression of basal lamina protein mRNAs in the early embryonic chick eye．J Comp Neurol，2002，447：261—273
26 Funatsu H，Yamashita H．Pathophysiology of diabetic retinopathy．Drug News Perspect，2002，15：633—639
27 Funatsu H，Yamashita H，Noma H，et al．Stimulation and inhibition of angiogenesis in diabetic retinopathy．Jpn J Ophthalmol，2001，45：577—584
28 Funatsu H，Yamashita H，Noma H，et al．Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin．Invest Ophthalmol Vis Sci，2003，44：1042—1047
29 Le Gat L，Gogat K，Bouquet C，et al．In vivo adenovirus－mediated deliv－ery of a uPA／uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy．Gene Ther，2003，10：2098—2103
30 Mori K，Ando A，Gehlbach P，et al．Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin．Am J Pathol，2001，159：313—320
31 Auricchio A，Behling KC，Maguire AM，et al．Inhibition of retinal neovascularization by intraocular viral－mediated delivery of anti－angiogenic agents．Mol Ther，2002，6：490—494
32 Jung SP，Siegrist B，Hornick CA，et al．Effect of human recombinant endostatin protein on human angiogenesis．Angiogenesis，2002，5：111—118
33 Wickstrom SA，Veikkola T，Rehn M．Endostatin－induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells．Cancer Res，2001，61：6511—6516
34 Dixelius J，Larsson H，Sasaki T，et al．Endostatin－induced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis．Blood，2000，95：3403—3411
35 Hanai J，Dhanabal M，Karumanchi SA，et al．Endostatin causes G1arrest of endothelial cells through inhibition of cyclin D1．J Biol Chem，2002，277：16464—16469
36 Urbich C，Reissner A，Chavakis E，et al．Dephosphorylation of endothelial nitric oxide synthase contributes to the anti－angiogenic effects of endostatin．FASEB J，2002，16：706—708
37 Takahashi K，Saishin Y，Saishin Y，et al．Intraocular expression of endostatin reduces VEGF－induced retinal permeability，neovascularization，and retinal detachment．FASEB J，2003，17：896—898
38 Caudell EG，Mumm JB，Poindexter N，et al．The protein product of the tumor suppressor gene，melanoma differentiation－associated gene－7，exhibits immunostimulatory activity and is designated IL－24．J Immunol，2002，168：6041—6046
39 Huang EY，Madireddi MT，Gopalkrishnan RV，et al．Genomic structure，chromosomal localization and expression profile of a novel melanoma differentiation associated（mda－7）gene with cancer specific growth suppressing and apoptosis inducing properties．Oncogene，2001，20：7051—7063
40 Blumberg H，Conklin D，Xu WF，et al．Interleukin－20：discovery，receptor identification and role in epidermal function．Cell，2001，104：9—19
41 Gallagher G，Dickensheets H，Eskdale J，et al．Cloning，expression and initial characterization of interleukin－19（IL－19），a novel homologue of human interleukin－10（IL－10）．Genes Immun，2000，1：442—450
42 Mhashilkar AM，Schrock RD，Hindi M，et al．Melanoma differentiation associated gene－7（mda－7）：a novel anti－tumor gene for cancer gene therapy．Mol Med，2001，7：271—282
43 Schaefer G，Venkataraman C，Schindler U．Cutting edge：FISP（IL－4induced secreted protein），a novel cytokine－like molecule secreted by Th2 cells．J Immunol，2001，166：5859—5863
44 Wang M，Tan Z，Zhang R，et al．Interleukin－24（MDA－7／MOB－5）signals through two heterodimeric receptors，IL－22R1／IL－20R2and IL－20R1／IL－20R2．J Biol Chem，2002，277：7341—7347
45 Nagalakshmi ML，Murphy E，McClanahan T，et al．Expression pattern of IL－10ligand and receptor gene families provide leads for biological characterization．Int Immunopharmacol，2004，4，2004，4：577—592
46 Sauane M，Gopalkrishnan RV，Sarkar D，et al．MDA－7／IL－24：Novel cancer growth suppressing and apoptosis inducing cytokine．Cytokine Growth Factor Rev，2003，14：35—51
47 Saeki T，Mhashilker A，Swanson X，et al．Inhibition of human lung cancer growth following adenovirus－mediated mda－7gene expression in vivo．Oncogene，2002，21：4558—4566
48 Ramesh R，Mhashilkar AM，Tanaka F，et al．Melanoma differentiation associated gene－7／interleukin－24is a novel ligand that regulates angiogenesis via IL－22receptor．Cancer Res，2003，63：5105—5113
49 Geiger JH，Cnudde SE．what the structure of angiostatin may tell us about its mechanism of action．Journal of thrombosis and haemostasis，2004，2：23—34
50 Gabison E，Chang JH，et al．Anti－angiogenic role of angiostatin during corneal wound healing．Exp Eye Res，2004，78：579—589
51 Gonzalez C，Corbacho AM，Eiserich JP，et al．16K－Prolactin Inhibits Activation of Endothelial Nitric Oxide Synthase，Intracellular Calcium Mobilization and Endothelium－Dependent Vasorelaxation．The Endocrine Society，2004，145（12）：5714—5722
52 Ando A，Yang A，Nambu H，et al．Blockade of Nitric－Oxide Synthase Reduces Choroidal Neovascularization．Mol．Pharmacol，2002，62；539—545
53 陈建苏，徐锦堂．角膜新生血管．眼科，2001，10（3）：137—143
54 Carmen G，et al．16K－Prolactin Inhibits Activation of Endothelial Nitric Oxide Synthase，Intracellular Calcium Mobilization，and Endothelium－Dependent Vasorelaxation．The Endocrine Society，2004，145（12）：5714—5722
55 Ochoa A．et al．Expression of Prolactin Gene and Secretion of Prolactin by Rat Retinal Capillary Endothelial Cells．Investigative Ophthalmology＆Visual Science，2001，42（7）：1639—1645
56 Corbacho A，Macotela Y，Nava G，et al．Human umbilical vein endothelial cells express multiple prolactin isoforms．J Endocrinol，2000，166：53—62
57 王 伟．视网膜与新生血管抑制因子．国外医学·眼科学分册，2003，27（3）：180—183
58 Funaki H，Sawaguchi S，Yaoeda K，et al．Expression and localization of angiogenic inhibitory factors，Chondromodulin－Ⅰ，in adult rat eye．Invest Ophthalmol Vis Sci，2001，42：1193—1200
59 Fukushima A，Funaki H，Yaoeda K，et al．Localization and Expression of Chondromodulin－Ⅰin the rat cornea．Arch Histol Cytol，2003，66：445—452
60 徐勤枝．白介素－4受体信号转导研究进展．国外医学·免疫学分册，2001，24：302—305．
61 卢 巍，梁 标．白介素－4和支气管哮喘．国外医学·呼吸系统分册，2001，21：125—129
62 钟晓方，雷春莲．干扰素－γ和白介素－4对RSV感染免疫病理中IgE调节作用的研究．国外医学·妇幼保健分册，2000，11：77—80
63 Paulukat J，Bosmann M，Nold M，et al．Expression and release of IL－18 binding protein in response to IFN－gamma．J Immunol，2001，167：7038—7043
64 Cao R，Famebo J，Kurimoto M，et al．Interleukin－18act as an angiogenesis and tumor suppressor．Clin Cancer Res，2003，9：2357—2365
65 Wigginton JM，Lee JK，Wiltrout TA，et al．Synergistic engagement of an ineffective endogenous anti－tumor immune response and induction of IFN－gamma and Fas－ligand－dependent tumor eradication by combined administration of IL－18and IL－2．J Immunol，2002，169：4467—4474